about
Factoring in Factor VIII With Acute Ischemic StrokeGene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.ABO genotype and risk of thrombotic events and hemorrhagic stroke.Procoagulant factors and the risk of myocardial infarction in young women.Acute myocardial infarction complicating active ulcerative colitis: a case report.Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?Elevated factor VIII levels and risk of venous thrombosis.Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.Recurrent myocardial infarctions in a young football player secondary to thrombophilia, associated with elevated factor VIII activity.A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation.Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional proteinCellular mechanisms of the hemostatic effects of desmopressin (DDAVP).Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitorEvaluation of Factor VIII as a Risk Factor in Indian Patients with DVT.Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state.Identifying novel genetic determinants of hemostatic balance.A case of acute pulmonary thromboembolism after taking tadalafil.Clotting factor VIII (FVIII) and thrombin generation in camel plasma: A comparative study with humansContribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases.Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo.Genetic variations and their influence on risk and treatment of venous thrombosis.A Model for Predicting Persistent Elevation of Factor VIII among Patients with Acute Ischemic Stroke.Testing children for inherited thrombophilia: more questions than answers.Preeclampsia and ABO blood groups: a systematic review and meta-analysis.Interaction between VWF and FVIII in treating VWD.Predicting dose sparing benefit and bleeding risk of pharmacokinetic-based personalized prophylactic dosing of factor VIII products.Laboratory assessment of sudden sensorineural hearing loss: A case-control study.Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.Temporary relief of symptomatic Von Willebrand disease by multiple myeloma.Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII.The association of non-O blood group and severity of liver fibrosis in patients with chronic hepatitis C infection.The imbalance of procoagulant and anticoagulant factors in patients with chronic liver diseases in North India.Hyperhomocysteinemia and venous thrombosis.Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice.Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study.Ex vivo thrombin generation in patients with venous thromboembolic disease or atrial fibrillation on long-term oral anticoagulation.Association between ABO blood group and fibrosis severity in chronic hepatitis C infection.Risk factors for cryptogenic ischaemic stroke.
P2860
Q28087052-FC545D92-3C12-4030-BAF0-C8FCB813D389Q30300355-4369FB08-AD1E-44F4-A911-3BD3A6BC4097Q30496759-A8C155AA-7391-49A7-97C9-DBBAF78AF399Q33370819-46469395-B74D-4CA6-9DCF-2B7B6E649057Q33559609-8839EF09-1B80-406B-A975-736433F4D6DAQ33896811-EE620275-C255-43CD-9E4C-139786AB4093Q34270700-9A813739-2140-42D8-A6B9-2E157BFC5DEBQ34404185-EFF8430B-3D1A-42A9-AA9B-9C6862C16F82Q34464688-99EBC4F8-1086-400C-8B29-C86CB7EC635CQ34499164-31E925D7-4F33-476C-BB4B-E009FB7AB60FQ34707266-D45F1DE6-961E-4F49-8F58-8221FA666850Q35181717-9D4024A9-4580-4406-95DD-1ED554650C26Q35690807-BA67A46D-F04C-40C4-B8AA-D546C707E681Q35750010-56AFE718-1677-4638-B198-3DDC36F54E0BQ36059509-C8DC1AB7-6A41-402F-B576-A4E9ADE2FE37Q36154476-1B303840-EDF9-4F40-B0E0-BDA8CC5AC8F0Q36230809-0D1781E4-5403-4E29-9854-6ACAEA4D3536Q36381067-05659E4B-C6FD-474D-BCFE-19258ED77991Q36709432-75E23BA2-63AB-42E8-9D89-E0CF0148D224Q36851942-4826942D-E4F0-40DD-B171-2791DD0E78BBQ36944538-D2A03DFD-16ED-4274-BD37-D7F0E5AF6906Q37076404-3D4A9D58-9E97-43AC-9D41-2248C0C17763Q37126654-DAAAF331-57D1-44DE-B6F3-2884AEA5F33FQ37255415-E763E804-8E96-44A9-A0A3-C1B32B9F8BD4Q37572819-EF51272B-3FA3-4C86-B6E4-A5B12AFE1391Q38062833-D518D134-7EBC-4E8B-8F46-61F90545B31FQ38326080-2A8FA5B0-12D9-4329-B921-449DE56B8A3FQ38764214-3A6DC3AC-E6AB-4618-9BAB-633A71FFEC46Q38948695-CB3E6262-4F4F-4CD3-BAC0-F774BCE2831BQ38953180-DA66DE3D-0EB7-4650-BF8A-D013F760701AQ39367487-41F61B8A-0A6D-49AE-874D-5B472ABAD133Q39623961-8F20327B-5CE6-4806-B749-F62DBD90DB78Q40037618-0D654D04-06BA-4FCD-A246-5F1D58FBCCF8Q40126497-4310D407-E019-45DF-A0BC-BCAB95BD58F4Q40425156-E6F49E21-2A3C-4A0E-9741-FA106E448782Q40600288-BB7E63BD-F294-4505-8FE3-8EB370582180Q41492090-6224D34D-8912-45F6-9D20-89A3C068984DQ42163618-4DBEBF65-2DDC-435A-96C1-04E51AD0FB68Q43030773-DFEF5A5A-80AA-4A59-B9B4-15C9FD5ACCE5Q44230227-EE4FD8E9-A968-4AC8-9AEC-D853E08AAE2E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Elevated factor VIII levels and the risk of thrombosis.
@ast
Elevated factor VIII levels and the risk of thrombosis.
@en
Elevated factor VIII levels and the risk of thrombosis.
@nl
type
label
Elevated factor VIII levels and the risk of thrombosis.
@ast
Elevated factor VIII levels and the risk of thrombosis.
@en
Elevated factor VIII levels and the risk of thrombosis.
@nl
prefLabel
Elevated factor VIII levels and the risk of thrombosis.
@ast
Elevated factor VIII levels and the risk of thrombosis.
@en
Elevated factor VIII levels and the risk of thrombosis.
@nl
P2093
P356
P1476
Elevated factor VIII levels and the risk of thrombosis.
@en
P2093
Bertina RM
Eikenboom JC
Kamphuisen PW
P304
P356
10.1161/01.ATV.21.5.731
P407
P577
2001-05-01T00:00:00Z